AZD8566 Food Effect/Microtracer Study

Study identifier:D1320C00011

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open, randomised, Phase I, 2-Period Crossover Trial to Investigate the Absolute Bioavailability and the Effect of Food on the Oral Bioavailability of AZD8566 in Healthy Volunteers

Medical condition

Healthy Volunteer Study

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD8566, AZD8566 IV carbon labelled

Sex

All

Actual Enrollment

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 Mar 2009

Primary Completion Date: 01 Mar 2009

Study Completion Date: 01 Apr 2009

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Nottingham, United Kingdom

Arms	Assigned Interventions

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1750&filename=CSR-D1320C00011.pdf
Download
CSR-D1320C00011.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

Pharmaceutical Profiles

01159 74 9000

enquiry@pharmprofiles.co.uk

Investigators

Principal Investigator

Jo Collier

Pharmaceutical Profiles, Mere Way, Ruddington Fields, Nottingham NG11 6JS